Focused senior expertise across the Canadian access landscape

Market Access Strategy

We help clients develop practical, payer-informed access strategies built for the Canadian market.

Our support can include

• Defining market access objectives and priorities
• Developing access and reimbursement strategies
• Mapping payer decision drivers and relevant precedents
• Assessing potential access opportunities and barriers
• Developing launch and pre-launch access plans
• Identifying evidence gaps and strategies to address them
• Supporting strategic decision-making as evidence and the competitive landscape evolve

Our focus is on translating complexity into clear strategic choices that teams can act on.

Payer & HTA Advisory

Understanding how payers and HTA bodies are likely to view a product is central to successful market access. We provide strategic insight into the Canadian payer and HTA environment.

Including

• CADTH and INESSS considerations
• Provincial reimbursement decision-making
• Public and private payer perspectives
• Payer evidence expectations
• Clinical and economic value drivers
• Relevant HTA precedents and reimbursement decisions
• Potential sources of uncertainty or resistance
• Risk mitigation strategies

We help clients move beyond simply understanding an HTA process to thinking strategically about how their evidence and value proposition are likely to be interpreted by decision-makers.

Evidence & Value Strategy

Strong clinical evidence does not automatically translate into strong payer value. We help clients identify and communicate the elements of their evidence that are most relevant to reimbursement decision-making.

Our work includes

• Evidence gap assessment
• Targeted literature reviews
• HTA precedent assessment
• Interpretation of previous reimbursement decisions
• Endpoint and outcome considerations
• Payer-relevant clinical positioning
• Value narrative development
• Translation of clinical and real-world evidence into payer-relevant messages

The goal is a clear, credible and differentiated value story that can support both internal decision-making and external payer engagement.

Payer & Stakeholder Research

When the available evidence does not answer the strategic question, direct stakeholder insight can be invaluable. We design and conduct focused payer and HTA research to address specific market access questions.

This can include

• Research objectives and study design
• Payer and HTA discussion guides
• Stakeholder interviews
• Public and private payer research
• Qualitative insight generation
• Cross-market comparisons
• Synthesis of findings into clear strategic implications

We focus on actionable insight, not simply a collection of interview quotes.

Canadian HTA Strategy & Submission Direction

We provide senior strategic guidance for Canadian HTA submissions, including CADTH, INESSS and provincial reimbursement considerations.

Our role can include

• Submission strategy and positioning
• Evidence strategy
• Identification of potential evidence gaps
• Assessment of key HTA risks
• Clinical and value positioning
• Anticipation of potential reviewer and payer concerns
• Strategic direction for submission content
• Review and challenge of draft materials
• Development of risk mitigation approaches

Pricing & Reimbursement

Pricing is inseparable from access strategy. We help clients understand the relationship between pricing, evidence, clinical value and reimbursement expectations in Canada.

Our work can include

• Canadian pricing strategy
• Reimbursement considerations
• Price and access trade-offs
• Payer perceptions of value
• Pricing precedents
• PMPRB considerations
• Strategic input into pricing submissions
• Integration of pricing strategy with broader market access planning